For CD8+ T cells to have an effector function, its specificity towards tumor antigen is induced beforehand, in a process called T cell priming, mediated by antigen-presenting cells (APCs) such as dendritic cells (DCs) [7]. This evidence concerns the gene CD8A and neoplasm.